GMP Cytokines Market Size, Share, and Industry Report [2031]
GMP Cytokines Market Size, Share, and Industry Report [2031]
Segments - Global GMP Cytokines Market by Products (TNF, Growth Factor, Interleukin, and Others), Applications (Tissue-engineered Products, Cell/Gene Therapy, and Others), and Regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast, 2023-2031
Upcoming
| Report ID :HC-3893
| 4.3 Rating
| 53 Reviews
| 202 Pages
| Format :
Report Description
The global GMP cytokines market size was valued at USD 105.87 Million in 2022 and is projected to reach USD 208.13 Million by 2031, expanding at a CAGR of 7.8% during the forecast period, 2023–2031. The market growth is attributed to rising prevalence of cancer and increasing healthcare spending globally.
The use of cytokines is to stimulate immune systems of cancer patients and it has long been one of the key processes for cancer treatment. As cancer becomes a major burden in the healthcare industry, the expansion of GMP cytokines in the cancer treatment has been under current clinical cancer research.
One of the approved cytokines for adjuvant treatment of resistant cancers is interferon-alpha. Several studies have shown that cytokines can inhibit tumor cell proliferation by having a direct anti-proliferative or pro-apoptotic effect. Ex vivo cultures, cell and gene therapy, and other therapeutic techniques are some of the vital treatment methods that extensively use GMP cytokines for cell proliferation and differentiation.
Furthermore, they are used in a variety of tissue engineered products for clinical usage. In addition, substantial research on cytokines is being undertaken in order to find new treatment ways to treat chronic diseases. According to the World Health Organization, cancer caused roughly 9.6 million deaths worldwide in 2019.
Market Drivers, Restraints, and Opportunities
-
Increasing adoption of cytokines in cancer and autoimmune therapies as well as their potential contribution in stem cell therapy are driving the market.
-
Massive investments and collaborations among players aiming at developing cytokine therapeutics for cancer and autoimmune illnesses are likely to propel the market during the forecast period.
-
High cost of GMP cytokines therapy is expected to stifle market expansion in the coming years.
-
Ongoing R&D programs for the advancement of treatment methods and diagnostic devices for cancer patients are creating lucrative opportunities for market expansion.
Scope of GMP Cytokines Market Report
The report on the global GMP cytokines market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.
|
Attributes |
Details |
|
Report Title |
GMP Cytokines Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016-2021 |
|
Forecast Period |
2023-2031 |
|
Segmentation |
Products (TNF, Growth Factor, Interleukin, and Others) and Applications (Tissue-engineered Products, Cell/Gene Therapy, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players covered in the Report |
Synthekine Inc.; Miltenyi Biotec; Lonza; PeproTech, Inc.; REPROCELL Inc.; Creative Bioarray; Sino Biological Inc.; Bio-Techne; Akron Biotech; and Sartorius CellGenix GmbH. |
GMP Cytokines Market Segment Insights
On the basis of products, the GMP cytokines market is divided into TNF, interleukin, growth factor, and others. The TNF segment is expected to grow at a fast rate during the forecast period owing to wide use of the products for various applications including research on immune cells system. Tumor necrosis factor-alpha is a tiny protein that helps to regulate immune cells.
This means that, when white blood cells detect infection, they produce TNF to notify the cells of immune system. However, TNF has the ability to cause apoptosis, fever, inflammation, and cachexia though it acts as suppress carcinogenesis and viral multiplication.
Based on applications, the market is fragmented into tissue-engineered products, cell/gene therapy, and others. The cell/gene therapy accounted for a large market share in 2019 and is projected to register a high CAGR during the forecast period. The segment growth is attributed to extensive adoption of the technology for tissue-engineering and other clinical research purposes.
In terms of regions, the GMP cytokines market is classified as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to dominate the market owing to factors such as the rising prevalence of cancer and strong ongoing genome research in the region. Many organizations in this region are spending money on research and development as well as raising awareness about cancer and its treatment.
Furthermore, governments are investing funding in cancer research and related programs. For example, the Canadian Institutes of Health Research (CIHR) spent USD 156 million on cancer research in 2015–2016, accounting for 16% of its overall grant and award investments. Furthermore, the CIHR provided about USD 68 million in funding for cancer immunotherapy research.
Segments
The global GMP cytokines market has been segmented on the basis of
Products
- TNF
- Growth Factor
- Interleukin
- Others
Applications
- Tissue-engineered Products
- Cell/Gene Therapy
- Others
Regions
- North America
- Europe
- Latin America
- Asia Pacific
- Middle East & Africa
Key Players
- Synthekine Inc.
- Miltenyi Biotec
- Lonza
- PeproTech, Inc.
- REPROCELL Inc.
- Creative Bioarray
- Sino Biological Inc.
- Bio-Techne
- Akron Biotech
- Sartorius CellGenix GmbH
Competitive Landscape
Major players in the global GMP cytokines market are Synthekine Inc.; Miltenyi Biotec; Lonza; PeproTech, Inc.; REPROCELL Inc.; Creative Bioarray; Sino Biological Inc.; Bio-Techne; Akron Biotech; and Sartorius CellGenix GmbH. Some of these players have adopted certain key development strategies such as launching of new products, entering into partnerships or collaboration, and expansion of manufacturing units to increase their market share.
- Synthekine Inc., for example, received USD 82 million in series fundraising in September 2020 in a view to focus on the development of cytokine therapies for cancer and autoimmune diseases.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. GMP Cytokines Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. GMP Cytokines Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. GMP Cytokines Market - Supply Chain
4.5. Global GMP Cytokines Market Forecast
4.5.1. GMP Cytokines Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. GMP Cytokines Market Size (000’ Units) and Y-o-Y Growth
4.5.3. GMP Cytokines Market Absolute $ Opportunity
5. Global GMP Cytokines Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. GMP Cytokines Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global GMP Cytokines Demand Share Forecast, 2019-2026
6. North America GMP Cytokines Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America GMP Cytokines Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America GMP Cytokines Demand Share Forecast, 2019-2026
7. Latin America GMP Cytokines Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America GMP Cytokines Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America GMP Cytokines Demand Share Forecast, 2019-2026
8. Europe GMP Cytokines Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe GMP Cytokines Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe GMP Cytokines Demand Share Forecast, 2019-2026
9. Asia Pacific GMP Cytokines Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific GMP Cytokines Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific GMP Cytokines Demand Share Forecast, 2019-2026
10. Middle East & Africa GMP Cytokines Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa GMP Cytokines Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa GMP Cytokines Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global GMP Cytokines Market: Market Share Analysis
11.2. GMP Cytokines Distributors and Customers
11.3. GMP Cytokines Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Synthekine Inc.
11.4.2. Miltenyi Biotec
11.4.3. Lonza
11.4.4. PeproTech, Inc.
11.4.5. REPROCELL Inc.
11.4.6. Creative Bioarray
11.4.7. Sino Biological Inc.
11.4.8. Bio-Techne&l
Methodology
Related Reports
Some other reports from this category!
Our Clients
